Treatment history predicts lung cancer risk in patients with Hodgkin's disease
NEW YORK (Reuters Health) – Hodgkin's disease patients who have been treated with alkylating agents and/or radiotherapy are more than four times as likely to
לקבלת קוד אימות לנייד ולמייל, יש למלא את כתובת המייל ואת מספר הטלפון שלך
NEW YORK (Reuters Health) – Hodgkin's disease patients who have been treated with alkylating agents and/or radiotherapy are more than four times as likely to
NEW YORK (Reuters Health) – A review of the use of percutaneous radiofrequency thermal ablation (RFA) of localized tumors suggest that it is an effective
NEW YORK (Reuters Health) – Chemotherapy plus radiotherapy can produce "relatively good" long-term results in patients with inoperable squamous cell carcinoma of the esophagus, according
NEW YORK (Reuters Health) – Octreotide, a long-acting somatostatin analogue, is an effective antitumor treatment for some patients with progressive malignant gastrinoma, according to a
NEW YORK (Reuters Health) – Among fit elderly patients undergoing aggressive platinum-based therapy for non-small-cell lung cancer, the response rates, toxicity levels, and survival rates
NEW YORK (Reuters Health) – Patients with multiple sclerosis who experience breakthrough symptoms during treatment with interferon beta-1a (Avonex; Biogen, Cambridge, Massachusetts) may benefit from
LONDON (Reuters Health) – The accuracy of core-cut biopsies in determining breast cancer grade increases as the number of needle passes increases, but at four
WESTPORT, CT (Reuters Health) – Evidence from Singapore indicates that intake of dietary soy food and a longer menopausal cycle protect against lung cancer in
LONDON (Reuters Health) – While there was a threefold increase in the incidence of testicular cancer in Denmark between 1945 to 1995, results of a
NEW YORK (Reuters Health) – Even very young children can develop medullary thyroid carcinoma when they bear the RET proto-oncogene mutation, which causes multiple endocrine
WASHINGTON (Reuters Health) – Switzerland's Novartis AG said on Friday that it has received approval from the US Food and Drug Administration (FDA) to market
By Will Boggs, MD NEW YORK (Reuters Health) – Polymorphisms in the genes for three enzymes involved in biotransformation of potential carcinogens increase the risk
By Steven Reinberg NEW YORK (Reuters Health) – Gene expression patterns seen on DNA microarrays can identify breast cancers that are likely to metastasize, according
By Anthony J. Brown, MD NEW YORK (Reuters Health) – Analyzing fecal DNA for mutations of the adenomatous polyposis coli (APC) gene can identify early
By Faith Reidenbach NEW YORK (Reuters Health) – For breast cancer patients who undergo neoadjuvant chemotherapy and mastectomy without radiation, the risk of local-regional recurrence
NEW YORK (Reuters Health) – Contrary to what has been thought, preemptive therapy does not diminish the incidence of ganciclovir-resistant cytomegalovirus (CMV) infections among lung
By Stephen Pincock GRONINGEN, The Netherlands (Reuters Health) – American and Dutch researchers have made gene therapy viral vectors up to 10,000 times better at
LONDON (Reuters Health) – A new type of intensive chemotherapy using weekly cisplatin and daily oral etoposide is "highly effective" in women with platinum-refractory ovarian
NEW YORK (Reuters Health) – As prevention for colorectal cancer, colonoscopy once every 10 years saves more lives at a lower cost than chemoprevention with
By Will Boggs, MD NEW YORK (Reuters Health) – Systolic BP variability in midlife may lead to the development of brain white matter lesions (WMLs)
ניתן להשתמש בחצי המקלדת ובמקש Esc לפתיחה וסגירה.